Caprock Group’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$344K Sell
6,327
-2,556
-29% -$124K 0.01% 985
2026
Q1
$381K Buy
8,883
+1,042
+13% +$44.8K 0.01% 839
2025
Q4
$344K Sell
7,841
-527
-6% -$21.8K 0.01% 949
2025
Q3
$313K Buy
+8,368
New +$336K 0.01% 928
2023
Q1
Sell
-20,945
Closed -$336K 654
2022
Q4
$336K Buy
20,945
+228
+1% +$3.72K 0.03% 371
2022
Q3
$325K Buy
20,717
+92
+0.4% +$1.78K 0.03% 378
2022
Q2
$429K Buy
20,625
+100
+0.5% +$2.06K 0.04% 296
2022
Q1
$465K Hold
20,525
0.04% 309
2021
Q4
$375K Buy
20,525
+9,712
+90% +$186K 0.03% 354
2021
Q3
$229K Buy
+10,813
New +$201K 0.02% 464

Other funds holding EXEL

Caprock Group's EXEL Position: Q2 2026 in Review

Caprock Group reduced its Exelixis (EXEL) stake by 29% in Q2 2026, selling an estimated $124K and leaving 6,327 shares worth $344K. The position accounts for 0.01% of the portfolio, ranked #985.

Caprock Group first reported a position in EXEL in Q3 2021 and has held it in 10 quarters since. The position peaked at $465K in Q1 2022. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Caprock Group held 6,327 shares of Exelixis worth $344K as of Q2 2026.
  • Caprock Group sold 2,556 Exelixis shares in Q2 2026, an estimated $124K.
  • Exelixis made up 0.01% of Caprock Group's portfolio in Q2 2026, its #985 holding.
  • Caprock Group first reported a position in Exelixis in Q3 2021 and has held it in 10 quarters since.
  • Caprock Group's Exelixis position peaked at $465K in Q1 2022.
  • 758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Caprock Group's 13F filing for Q2 2026, filed 27 Jul 2026.